DK2663366T3 - Aminosyresammensætning og anvendelse deraf til behandling af intrauterin fostervæksthæmning (iugr) eller til parenteral ernæring af meget for tidligt fødte - Google Patents

Aminosyresammensætning og anvendelse deraf til behandling af intrauterin fostervæksthæmning (iugr) eller til parenteral ernæring af meget for tidligt fødte Download PDF

Info

Publication number
DK2663366T3
DK2663366T3 DK12701665.7T DK12701665T DK2663366T3 DK 2663366 T3 DK2663366 T3 DK 2663366T3 DK 12701665 T DK12701665 T DK 12701665T DK 2663366 T3 DK2663366 T3 DK 2663366T3
Authority
DK
Denmark
Prior art keywords
iugr
treatment
amino acid
acid composition
growth inhibition
Prior art date
Application number
DK12701665.7T
Other languages
English (en)
Inventor
Michael Tchirikov
Original Assignee
Michael Tchirikov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Tchirikov filed Critical Michael Tchirikov
Application granted granted Critical
Publication of DK2663366T3 publication Critical patent/DK2663366T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK12701665.7T 2011-01-13 2012-01-06 Aminosyresammensætning og anvendelse deraf til behandling af intrauterin fostervæksthæmning (iugr) eller til parenteral ernæring af meget for tidligt fødte DK2663366T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11000211A EP2489408A1 (de) 2011-01-13 2011-01-13 Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
PCT/EP2012/000045 WO2012095281A1 (de) 2011-01-13 2012-01-06 Aminosäurezusammensetzung und deren verwendung zur behandlung von intrauteriner fetaler wachstumsrestriktion (iugr) oder zur parenteralen ernährung von extrem frühgeborenen

Publications (1)

Publication Number Publication Date
DK2663366T3 true DK2663366T3 (da) 2020-11-09

Family

ID=43982439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12701665.7T DK2663366T3 (da) 2011-01-13 2012-01-06 Aminosyresammensætning og anvendelse deraf til behandling af intrauterin fostervæksthæmning (iugr) eller til parenteral ernæring af meget for tidligt fødte

Country Status (11)

Country Link
EP (2) EP2489408A1 (da)
DK (1) DK2663366T3 (da)
EA (1) EA028055B8 (da)
ES (1) ES2829205T3 (da)
HR (1) HRP20201774T1 (da)
HU (1) HUE051736T2 (da)
PL (1) PL2663366T3 (da)
PT (1) PT2663366T (da)
RS (1) RS60992B1 (da)
SI (1) SI2663366T1 (da)
WO (1) WO2012095281A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11596167B2 (en) * 2014-05-19 2023-03-07 N.V. Nutricia Formulas comprising optimised amino acid profiles
WO2016179657A1 (en) * 2015-05-11 2016-11-17 Newcastle Innovation Limited Amino acid supplementation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU678201B2 (en) 1992-12-22 1997-05-22 Baxter International Inc. Improved amino acid solutions for treatment of peritoneal dialysis patients
CN1120001C (zh) 1997-11-24 2003-09-03 曾忠铭 刺激阴道革兰氏阳性杆菌生长、增强阴道酸度的药剂和其用途
JP2000072669A (ja) 1998-08-24 2000-03-07 Inst Of Physical & Chemical Res アミノ酸・糖組成物
CA2617230A1 (en) * 2005-08-02 2007-02-08 Baxter International Inc. Medical products and parenteral formulations
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
JP5812565B2 (ja) 2007-02-28 2015-11-17 株式会社明治 アミノ酸組成物

Also Published As

Publication number Publication date
RS60992B1 (sr) 2020-11-30
EP2489408A1 (de) 2012-08-22
PT2663366T (pt) 2020-11-10
EP2663366B1 (de) 2020-08-05
HUE051736T2 (hu) 2021-03-29
EP2663366A1 (de) 2013-11-20
EA028055B1 (ru) 2017-10-31
WO2012095281A1 (de) 2012-07-19
PL2663366T3 (pl) 2020-12-28
SI2663366T1 (sl) 2021-01-29
EA028055B8 (ru) 2020-04-22
ES2829205T3 (es) 2021-05-31
HRP20201774T1 (hr) 2021-01-08
EA201391034A1 (ru) 2014-11-28

Similar Documents

Publication Publication Date Title
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2391222T3 (da) Mælk med lang holdbarhed og mælke-relaterede produkter samt fremgangsmåde og mælkebehandlingsanlæg til deres fremstilling
DK2935303T3 (da) 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
DK2470191T3 (da) Fremgangsmåder og præparater til forebyggelse eller behandling af oftalmiske tilstande
DK3238709T3 (da) Forbedrede parenterale formuleringer af lipofile farmaceutiske midler og fremgangsmåder til fremstilling og anvendelse af samme
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
HK1212260A1 (en) Solid substrates for promoting cell and tissue growth
DK2917358T3 (da) Sammensætninger og fremgangsmåder til biologisk fremstilling af fedtsyrederivater
DK2809169T3 (da) Mejeriprodukter med tilsatte mejerimineraler og fremgangsmåder til fremstilling af mejeriprodukter med tilsatte mejerimineraler
DK3134105T3 (da) Peptidanaloger med én eller flere forgrenede aminosyreprober
DK2721198T3 (da) Anordning til fremstilling af natriumhypochlorit eller hypochlorsyrling og vandbehandlingssystem generelt
DK2717914T3 (da) Depotformuleringer til administration af proteiner til øjet og fremgangsmåder til fremstilling deraf
DK3050561T3 (da) Sammensætninger af chlorogensyre og fremgangsmåder til fremstilling og anvendelse af samme i fedmehåndtering
DK3366307T3 (da) Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri
HK1205880A1 (en) Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
IL232384A0 (en) Use of preparations containing halofanate or halophanic acid to treat gout
DK2702992T3 (da) Anvendelse af melatonin til behandling af og/eller forebyggelse af mucositis
GB2583050B (en) Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid
DK3622810T3 (da) Fremgangsmåder og sammensætninger til forlængelse af holdbarheden af planteprodukter
DK2576782T3 (da) Sirna og anvendelse deraf i fremgangsmåder og sammensætninger til behandling og/eller forebyggelse af øjentilstande
DK2892556T3 (da) Sammensætninger og fremgangsmåder til behandling af sygdomme
SMT201600233B (it) Preparazione farmaceutica contenente selenite - o composti contenenti selenite per il trattamento di displasie cervicali o carcinomi cervicali
DK2612850T3 (da) Krystallinsk delta-form af argininsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette
DK2247573T3 (da) Kulsyre- og svovlsyresalte af 3-(2,2,2-trimethylhydrazinium)propionatstere af anvendelse deraf til fremstilling og 3-(2,2,2-trimethylhydrazinium)propionat-dihydrat
PL3237375T3 (pl) Kryształy prekursorów N-(kwas octowy) alaniny, sposób ich wytwarzania i ich zastosowanie